CVS Health is revolutionizing how it develops patient-facing technology by implementing "agentic twins"—highly sophisticated digital replicas of real consumers. By partnering with Simile, the healthcare giant has constructed these AI agents using over 2.9 million consented responses from a diverse pool of 400,000 individuals. This massive dataset allows the company to simulate how specific demographics might react to new services or communication styles before they ever reach a real person.

The core value of this approach lies in its ability to bridge the gap between traditional research and rapid software development. Unlike standard surveys that provide a one-time snapshot of user sentiment, these digital agents provide a continuous, interactive feedback loop. Developers use them to stress-test everything from mobile app workflows to the phrasing of medication refill reminders. This constant "voice of the customer" helps identify friction points—such as lack of trust or perceived inconvenience—that often lead to patients abandoning their treatment plans.

Beyond efficiency, the project emphasizes inclusivity and safety. The digital twins make it significantly easier to gather insights from underserved populations who are often underrepresented in traditional clinical or market research. However, CVS is not relying on simulation alone; the team operates under a strict governance framework to monitor for AI bias and ensure fairness. By combining these virtual test subjects with ongoing real-world validation, the company aims to build more empathetic and effective healthcare tools.

CVS Health is revolutionizing how it develops patient-facing technology by implementing "agentic twins"—highly sophisticated digital replicas of real consumers. By partnering with Simile, the healthcare giant has constructed these AI agents using over 2.9 million consented responses from a diverse pool of 400,000 individuals. This massive dataset allows the company to simulate how specific demographics might react to new services or communication styles before they ever reach a real person.

The core value of this approach lies in its ability to bridge the gap between traditional research and rapid software development. Unlike standard surveys that provide a one-time snapshot of user sentiment, these digital agents provide a continuous, interactive feedback loop. Developers use them to stress-test everything from mobile app workflows to the phrasing of medication refill reminders. This constant "voice of the customer" helps identify friction points—such as lack of trust or perceived inconvenience—that often lead to patients abandoning their treatment plans.

Beyond efficiency, the project emphasizes inclusivity and safety. The digital twins make it significantly easier to gather insights from underserved populations who are often underrepresented in traditional clinical or market research. However, CVS is not relying on simulation alone; the team operates under a strict governance framework to monitor for AI bias and ensure fairness. By combining these virtual test subjects with ongoing real-world validation, the company aims to build more empathetic and effective healthcare tools.